NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06605625 2025-10-28
VRiC
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04848493 2025-06-13
VAX4FRAIL
Azienda USL Reggio Emilia - IRCCS
Completed
NCT04784689 2023-05-25
Host Immune Response to Novel RNA COVID-19 Vaccination
The University of Texas Health Science Center at San Antonio
Completed
NCT04910295 2023-04-12
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Seoul National University Hospital
Completed
NCT04821570 2023-04-04
CANINE
University of Kansas Medical Center
Unknown
NCT05043246 2022-08-10
SIM-PBD
The Second Affiliated Hospital of Chongqing Medical University
Unknown
NCT05009030 2022-07-29
VAC-CaP
Fundación GECP
Completed